Miromatrix Medical P/E Ratio

Miromatrix Medical (MIRO) currently reports a P/E ratio of -2.34. That is below the Healthcare sector average of 25.72. Use the charts on this page to explore Miromatrix Medical's P/E ratio history and peer comparisons.

Miromatrix Medical's P/E ratio of -2.34 is lower than the Healthcare sector average of 25.72. That is roughly 109.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Miromatrix Medical's market price to a fundamental measure such as earnings, sales, or book value. At -2.34, MIRO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -2.34, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.72. From there, open related valuation or income-statement pages for Miromatrix Medical, and consider following MIRO for alerts when major investors trade the stock.

Miromatrix Medical is classified in the Healthcare sector. On P/E ratio, it currently shows -2.34 versus a sector average near 25.72. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MIRO with unrelated industries.